| # | Title | Journal | Year | Citations |
|---|
| 1 | The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2016 | 148 |
| 2 | COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 112 |
| 3 | Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 76 |
| 4 | National and State Estimates of COPD Morbidity and Mortality — United States, 2014-2015 | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 65 |
| 5 | Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2017 | 60 |
| 6 | Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the Future | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 42 |
| 7 | The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2017 | 42 |
| 8 | Comorbidities of COPD Have a Major Impact on Clinical Outcomes, Particularly in African Americans | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 40 |
| 9 | Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 38 |
| 10 | Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 38 |
| 11 | Chronic Pain in People With Chronic Obstructive Pulmonary Disease: Prevalence, Clinical and Psychological Implications | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2017 | 36 |
| 12 | Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 36 |
| 13 | Identifying Patients With COPD at High Risk of Readmission | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2016 | 35 |
| 14 | Clinical Characteristics of Patients With Biomass Smoke-Associated COPD and Chronic Bronchitis, 2004-2014 | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 32 |
| 15 | The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 31 |
| 16 | Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 31 |
| 17 | COPD at the Time of COVID-19: A COPD Foundation Perspective | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2020 | 30 |
| 18 | Pulmonary Subtypes Exhibit Differential Global Initiative for Chronic Obstructive Lung Disease Spirometry Stage Progression: The COPDGene® Study | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 29 |
| 19 | The Beneficial Effects of Antioxidants in Health and Diseases | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2020 | 29 |
| 20 | Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 28 |
| 21 | Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 28 |
| 22 | Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2015 | 26 |
| 23 | Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene® Cohort | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 26 |
| 24 | Progress in Imaging COPD, 2004 - 2014 | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 25 |
| 25 | National COPD Readmissions Summit 2013: Integrating COPD into Patient-Centered Hospital Readmissions Reduction Programs | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 25 |
| 26 | Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2021 | 24 |
| 27 | Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 24 |
| 28 | Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 23 |
| 29 | Journal Club—COPD2020 Update. Global Initiative for Chronic Obstructive Lung Disease 2020 Report and the Journal of the COPD Foundation Special Edition, Moving to a New Definition for COPD: “COPDGene® 2019” | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2020 | 23 |
| 30 | The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2017 | 22 |
| 31 | Alpha-1 Antitrypsin Therapy for Autoimmune Disorders | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 22 |
| 32 | Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 22 |
| 33 | Original Research Marijuana Use Associations with Pulmonary Symptoms and Function in Tobacco Smokers Enrolled in The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 21 |
| 34 | Longitudinal Computed Tomography and Magnetic Resonance Imaging of COPD: Thoracic Imaging Network of Canada (TINCan) Study Objectives | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 21 |
| 35 | The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 21 |
| 36 | Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 20 |
| 37 | Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2015 | 20 |
| 38 | Characteristics of COPD Patients Using United States Emergency Care or Hospitalization | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2016 | 20 |
| 39 | Chronic Bronchitis: Where Are We Now? | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 20 |
| 40 | St George’s Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2017 | 20 |
| 41 | GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2017 | 19 |
| 42 | Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 19 |
| 43 | Defining COPD-Related Comorbidities, 2004-2014 | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 19 |
| 44 | Pathophysiology of Emphysema and Implications | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2016 | 18 |
| 45 | New Therapeutic Targets for Alpha-1 Antitrypsin Deficiency | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 18 |
| 46 | Urban-Rural Disparities in Chronic Obstructive Pulmonary Disease Management and Access in Uganda | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 18 |
| 47 | Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2019 | 18 |
| 48 | Immunoglobulin E as a Biomarker for the Overlap of Atopic Asthma and Chronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2020 | 18 |
| 49 | Repeatability and Sample Size Assessment Associated with Computed Tomography-Based Lung Density Metrics | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2014 | 17 |
| 50 | Pattern and Adherence to Maintenance Medication Use in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease: 2008-2013 | Chronic Obstructive Pulmonary Diseases (Miami, Fla ) | 2018 | 17 |
